Additionally, the nuclear accumulation of PD-L1 can transactivate a range of pro-inflammatory and immune response transcription factors involved in the IRF, JAK - STATs and NF-κB signaling pathways (6), creating a positive feedback loop that further enhances nuclear PD-L1 expression and fosters tumor immune evasion. This evidence concerns the gene NFKB1 and neoplasm.